跳至主要内容
临床试验/IRCT20200628047940N1
IRCT20200628047940N1招募中3 期

Effect of probiotic (Lactobacilus sporogenesis) in reducing PELD score in pediatric cholestatic liver disease:Randomized double blinded clinical trial

Shiraz University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 year 至 12 years(—)
性别
All

入选标准

  • cholestatic liver failure
  • informed consent

排除标准

  • Taking antibiotics for four weeks before the study
  • Active microbial infection
  • History of gastrointestinal bleeding over the past two months
  • History of SBP over the past two months
  • Taking immunosuppressive drugs
  • Immunosuppressed patients
  • Renal failure ( creatinine> 1.5 mg)
  • Electronic imbalance (serum sodium <130 or> 150 meq / dl, serum potassium <3.0 or> 5.5 meq / dl)
  • History of Allergies

研究者

相似试验